Pennant Group (1ZU) Stock Forecast & Price Target

0 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

1ZU Analyst Ratings

Strong Buy

5 Buy

0 Hold

0 Sell

Based on 5 analysts giving stock ratings to

Pennant

Group

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

1ZU Stock 12 Month Forecast

Average Price Target

€36.63

▲(5.26% Upside)

Based on 5 Wall Street analysts offering 12 month price targets for Pennant Group in the last 3 months. The average price target is €36.63 with a high forecast of €38.94 and a low forecast of €34.61. The average price target represents a 5.26% change from the last price of €34.80.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"17":"€17","28":"€28","39":"€39","22.5":"€22.5","33.5":"€33.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":38.93835015,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€38.94</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":36.63089236333333,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€36.63</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":34.6118668,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€34.61</span>\n  </div></div>","useHTML":true}}],"tickPositions":[17,22.5,28,33.5,39],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,34.6,34.933719242307696,35.26743848461538,35.60115772692308,35.93487696923077,36.26859621153846,36.60231545384615,36.93603469615385,37.26975393846154,37.60347318076923,37.93719242307692,38.27091166538462,38.604630907692304,{"y":38.93835015,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,34.6,34.75622248948718,34.91244497897436,35.06866746846154,35.22488995794872,35.381112447435896,35.537334936923074,35.69355742641026,35.849779915897436,36.00600240538461,36.16222489487179,36.318447384358976,36.47466987384615,{"y":36.63089236333333,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,34.6,34.60091283076923,34.60182566153846,34.602738492307694,34.603651323076924,34.604564153846155,34.605476984615386,34.60638981538462,34.60730264615385,34.60821547692308,34.60912830769231,34.61004113846154,34.61095396923077,{"y":34.6118668,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":18.6,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.4,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.8,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.6,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":24.2,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":24.6,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":27.6,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":25.6,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":25.6,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":28.6,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":32.2,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":34.6,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€38.94

Average Price Target€36.63

Lowest Price Target€34.61

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

David S Macdonald

Truist Financial

―

Buy

―

Reiterated

08/06/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: ADMA Biologics (NASDAQ: ADMA), biote (NASDAQ: BTMD) and Pennant Group (NASDAQ: PNTG)

Jared Haase

William Blair

―

Buy

―

Reiterated

08/05/26

Analysts' Top Healthcare Picks: Pennant Group (PNTG), BeOne Medicines (ONC)

Stephen Baxter

Wells Fargo

€35.48→€38.94

Buy

11.89%

Upside

Reiterated

07/13/26

Pennant Group price target raised to $45 from $41 at Wells FargoPennant Group price target raised to $45 from $41 at Wells Fargo

Michael Wiederhorn

Oppenheimer

€32.02→€34.61

Buy

-0.54%

Downside

Reiterated

05/08/26

Pennant Group (PNTG) Receives a Buy from Oppenheimer

Ben Hendrix

RBC Capital

€35.48→€36.34

Buy

4.43%

Upside

Reiterated

05/07/26

RBC Capital Sticks to Their Buy Rating for Pennant Group (PNTG)

Unknown Analyst

Stephens

Not Ranked

Stephens

€26.26→€32.02

Buy

-8.00%

Downside

Reiterated

04/02/26

Pennant Group (PNTG) Gets a Buy from Stephens

Brian Tanquilut

Jefferies

€25.96→€34.61

Buy

-0.54%

Downside

Reiterated

12/16/25

Pennant Group price target raised to $40 from $30 at JefferiesPennant Group price target raised to $40 from $30 at Jefferies

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

David S Macdonald

Truist Financial

―

Buy

―

Reiterated

08/06/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: ADMA Biologics (NASDAQ: ADMA), biote (NASDAQ: BTMD) and Pennant Group (NASDAQ: PNTG)

Jared Haase

William Blair

―

Buy

―

Reiterated

08/05/26

Analysts' Top Healthcare Picks: Pennant Group (PNTG), BeOne Medicines (ONC)

Stephen Baxter

Wells Fargo

€35.48→€38.94

Buy

11.89%

Upside

Reiterated

07/13/26

Pennant Group price target raised to $45 from $41 at Wells FargoPennant Group price target raised to $45 from $41 at Wells Fargo

Michael Wiederhorn

Oppenheimer

€32.02→€34.61

Buy

-0.54%

Downside

Reiterated

05/08/26

Pennant Group (PNTG) Receives a Buy from Oppenheimer

Ben Hendrix

RBC Capital

€35.48→€36.34

Buy

4.43%

Upside

Reiterated

05/07/26

RBC Capital Sticks to Their Buy Rating for Pennant Group (PNTG)

Unknown Analyst

Stephens

Not Ranked

Stephens

€26.26→€32.02

Buy

-8.00%

Downside

Reiterated

04/02/26

Pennant Group (PNTG) Gets a Buy from Stephens

Brian Tanquilut

Jefferies

€25.96→€34.61

Buy

-0.54%

Downside

Reiterated

12/16/25

Pennant Group price target raised to $40 from $30 at JefferiesPennant Group price target raised to $40 from $30 at Jefferies

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

AVBPArriVent BioPharma, Inc.

BTSGBrightSpring Health Services, Inc.

ZURAZura Bio

TNYATenaya Therapeutics

JBIOJade Biosciences

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Pennant Group

3 Months

Michael WiederhornOppenheimer

Success Rate

12/17 ratings generated profit

Average Return

+7.98%

Copying Michael Wiederhorn's trades and holding each position for 3 Months would result in 70.59% of your transactions generating a profit, with an average return of +7.98% per trade.

1 Year

Michael WiederhornOppenheimer

Success Rate

14/17 ratings generated profit

Average Return

+52.58%

Copying Michael Wiederhorn's trades and holding each position for 1 Year would result in 82.35% of your transactions generating a profit, with an average return of +52.58% per trade.

2 Years

Michael WiederhornOppenheimer

Success Rate

17/17 ratings generated profit

Average Return

+67.91%

Copying Michael Wiederhorn's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +67.91% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

1ZU Analyst Recommendation Trends

Rating

Apr 26

May 26

Jun 26

Jul 26

Aug 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, 1ZU has received 6 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 1ZU average Analyst price target in the past 3 months is 36.63.

Each month's total comprises the sum of three months' worth of ratings.

1ZU Financial Forecast

1ZU Earnings Forecast

Next quarter’s earnings estimate for 1ZU is €0.30 with a range of €0.29 to €0.30. The previous quarter’s EPS was €0.31. 1ZU beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 58.33% of the time in the same period. In the last calendar year 1ZU has Performed in-line its overall industry.

1ZU Sales Forecast

Next quarter’s sales forecast for 1ZU is €253.31M with a range of €251.43M to €255.37M. The previous quarter’s sales results were €257.84M. 1ZU beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 66.67% of the time in the same period. In the last calendar year 1ZU has Performed in-line its overall industry.

1ZU Stock Forecast FAQ

What is DE:1ZU’s average 12-month price target, according to analysts?

Based on analyst ratings, Pennant Group Inc’s 12-month average price target is 36.63.

What is DE:1ZU’s upside potential, based on the analysts’ average price target?

Pennant Group Inc has 5.26% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Pennant Group Inc a Buy, Sell or Hold?

Pennant Group Inc has a consensus rating of Strong Buy, which is based on 5 buy ratings, 0 hold ratings and 0 sell ratings.

What is Pennant Group Inc’s share price target?

The average share price target for Pennant Group Inc is 36.63. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €38.94 ,and the lowest forecast is €34.61. The average share price target represents 5.26% Increase from the current price of €34.8.

What do analysts say about Pennant Group Inc?

Pennant Group Inc’s analyst rating consensus is a Strong Buy. This is based on the ratings of 5 Wall Streets Analysts.

How can I buy shares of Pennant Group Inc?

To buy shares of DE:1ZU, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Pennant Group (1ZU) Stock Forecast & Price Target

1ZU Analyst Ratings

1ZU Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Pennant Group

1ZU Analyst Recommendation Trends

1ZU Financial Forecast

1ZU Earnings Forecast

1ZU Sales Forecast

1ZU Stock Forecast FAQ

Detailed List of Analyst Forecasts